Trial Masters joins ZEINCRO to create specialist CRO in Central- and South-Eastern Europe
ZEINCRO, a specialist provider of clinical research services in Greece, Turkey and Cyprus, today announced it is consolidating with Trial Masters Ltd, a contract research organization managing clinical trials in Hungary and Romania.
Athens, Greece and Budapest, Hungary – June 11, 2012 – ZEINCRO, a specialist provider of clinical research services in Greece, Turkey and Cyprus, today announced it is consolidating with Trial Masters Ltd, a contract research organization managing clinical trials in Hungary and Romania.
With a team of more than 140 people and over a decade’s experience, the expanded ZEINCRO Group, will be ideally positioned to offer to its global drug development customers clinical trial services in a broader geographical region in Central- and South- Eastern Europe (CSEE).
“Adding Trial Masters to ZEINCRO Group will extend our geographic reach and allow us to work on larger-scale projects,” commented Prof. Gregory Sivolapenko, Chairman of ZEINCRO Group. “Both our teams have forged strong links with local authorities and the healthcare community, giving us a unique and in-depth understanding of the regions in which we operate and enabling us to deliver bespoke clinical research services that are flexible and ethical, maximizing patient recruitment and compliance.”
Supplementary to clinical research services in CSEE, ZEINCRO Group provides specialized services in risk management plans, pharmacovigilance, post-marketing safety and efficacy studies as well as regulatory affairs.
Trial Masters CEO, Dr János Demeter, added: “We are excited to be joining ZEINCRO Group. This is a natural fit as we both share the same core values and fundamental approach to successfully delivering clinical development programs. As we continue our local presence but also become part of a larger organization, we will be able to enhance the support we offer to our customers.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
